Finding 501508 (2023-002)

Significant Deficiency
Requirement
C
Questioned Costs
-
Year
2023
Accepted
2024-10-01
Audit: 323583
Organization: La Clinica Tepeyac (CO)

AI Summary

  • Core Issue: There is a significant deficiency in internal controls over compliance, specifically regarding the approval process for cash drawdowns of federal funds.
  • Impacted Requirements: The organization failed to meet the requirement for effective internal controls as outlined in §200.303 of 2 CFR Part 200, leading to potential mismanagement of federal funds.
  • Recommended Follow-Up: The organization should enhance its internal controls by ensuring all cash drawdown approvals are documented and verified before funds are requested.

Finding Text

Federal Agency: U.S. Department of Health and Human Services Federal Program: Consolidated Health Centers Grant AL Number: 93.224 & 93.527 Award Period: 1/1/23 - 12/31/23 Type of Finding: Significant Deficiency in Internal Control Over Compliance and Compliance Criteria or Specific Requirement According to §200.303 Internal controls of 2 CFR Part 200, the non-Federal entity must establish and maintain effective internal control over the Federal award that provides reasonable assurance that the non-Federal entity is managing the Federal award in compliance with Federal statutes, regulations, and the terms and conditions of the Federal award. Condition and Context During our testing, we noted the department was unable to provide documentation to support management review and approval of the cash drawdowns prior to the drawdown of the federal funds. Effect The Organization may drawdown the incorrect amount of federal funds. Questioned Costs None identified. Cause Management oversight. Approvals were done verbally and no documentation was recorded. Section III – Findings and Questioned Costs – Major Federal Programs (Continued) 2023-002 – Cash Management (Continued) Recommendation We recommend the Organization to review internal controls in regards to the approval of federal fund drawdown requests. Views of Responsible Officials The Organization has reviewed all of our internal controls to ensure all approvals are documented. The procedure has been updated to include preparing the draw documentation, entering accounts receivable invoice into the accounting system, which now requires an approval for all accounts receivable invoices. Once the accounts receivable invoices are approved in the accounting system then a drawdown can be requested in the payment management system.

Corrective Action Plan

Consolidated Health Centers Grant — Assistance Listing No. 93.224 & 93.527 Recommendation: Our auditors recommended the Organization to review internal controls in regards to the approval of federal fund drawdown requests. Explanation of disagreement with audit finding: There is no disagreement with the audit finding. Action taken in response to finding: The Organization has reviewed all of our internal controls to ensure all approvals are documented. The procedure has been updated to include preparing the draw documentation, entering accounts receivable invoice into the accounting system, which now requires an approval for all accounts receivable invoices. Once the accounts receivable invoices are approved in the accounting system then a drawdown can be requested in the payment management system

Categories

Cash Management Internal Control / Segregation of Duties Significant Deficiency Matching / Level of Effort / Earmarking

Other Findings in this Audit

  • 501507 2023-001
    Material Weakness Repeat
  • 501509 2023-001
    Material Weakness Repeat
  • 501510 2023-002
    Significant Deficiency
  • 501511 2023-001
    Material Weakness Repeat
  • 501512 2023-002
    Significant Deficiency
  • 501513 2023-001
    Material Weakness Repeat
  • 501514 2023-002
    Significant Deficiency
  • 501515 2023-001
    Material Weakness Repeat
  • 501516 2023-002
    Significant Deficiency
  • 1077949 2023-001
    Material Weakness Repeat
  • 1077950 2023-002
    Significant Deficiency
  • 1077951 2023-001
    Material Weakness Repeat
  • 1077952 2023-002
    Significant Deficiency
  • 1077953 2023-001
    Material Weakness Repeat
  • 1077954 2023-002
    Significant Deficiency
  • 1077955 2023-001
    Material Weakness Repeat
  • 1077956 2023-002
    Significant Deficiency
  • 1077957 2023-001
    Material Weakness Repeat
  • 1077958 2023-002
    Significant Deficiency

Programs in Audit

ALN Program Name Expenditures
93.224 Consolidated Health Center, Affordable Care Act for New and Expanded Services $882,406
93.224 American Rescue Plan Act Funding for Health Centers $468,758
93.914 Hiv Emergency Relief Project Grants $187,413
93.526 Health Center Infrastructure Support $185,723
93.527 Fy 2023 Expanding Covid-19 Vaccination $82,965
93.048 Special Programs for the Aging, Title Iv, and Title Ii, Discretionary Projects $73,871
93.185 Immunization Research, Demonstration, Public Information and Education Training and Clinical Skills Improvement Projects $60,386
93.898 Cancer Prevention and Control Programs for State, Territorial and Tribal Organizations $39,394
93.527 Fy 2023 Bridge Access Program $22,458
93.744 Breast and Cervical Cancer Screening Opportunities for States, Tribes and Territories $12,888
93.527 Consolidated Health Center, Affordable Care Act for New and Expanded Services $0